Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer

Seema S Ahuja, Margaret R. Brown, Thomas A. Fleisher, Sunil K Ahuja, Harry L. Malech

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Immunomodulatory cytokines have been used with success as adjunctive therapy in genetic disorders such as chronic granulomatous disease and infectious diseases such as leishmaniasis and leprosy. As the first step toward developing novel methods to deliver immunomodulatory cytokines, we used retrovirus-mediated somatic gene transfer techniques to produce IFN-γ from human peripheral blood CD34+ hemopoietic progenitor (PBHP) cells. After transduction, the PBHP cells were made to differentiate toward myelo- monocytic lineages. Only the PBHP-derived myelo-monocytic cells that were transduced with the IFN-γ cDNA produced IFN-γ (4 ± 1.3 ng of IFN-γ/106 PBHP cells). Despite a reduction in the proliferation of IFN-γ-transduced PBHP cells as well as a decrease in erythroid colony formation, there was an enhancement of monocyte differentiation and activation. Monocytes differentiated from the IFN-γ-transduced PBHP cells demonstrated 1) up- regulation of MHC class I and II Ag expression, 2) increased FcγRI expression, and 3) enhanced superoxide production in response to both opsonized zymosan (25-fold) and phorbol ester (3-fold). Furthermore, a functional response to a monocyte-specific chemokine, monocyte chemotactic protein-1 (mobilization of intracellular Ca2+) was seen only in the IFN- γ-transduced cells. Thus, PBHP cells transduced with IFN-γ cDNA produce not only biologically active IFN-γ, but also enhanced monocyte differentiation, resulting in an activated state that includes unique functions, such as responsiveness to monocyte chemotactic protein-1. These transduced activated monocytes may be specifically suited to cellular therapy requiring homing to sites of inflammation where their antimicrobicidal, cytotoxic, and APC functions plays an important role in host defense against foreign pathogens.

Original languageEnglish (US)
Pages (from-to)4345-4353
Number of pages9
JournalJournal of Immunology
Volume156
Issue number11
StatePublished - Jun 1 1996

Fingerprint

Stem Cells
Monocytes
Genes
Chemokine CCL2
Complementary DNA
Cytokines
Chronic Granulomatous Disease
Gene Transfer Techniques
Inborn Genetic Diseases
Zymosan
Leishmaniasis
Phorbol Esters
Leprosy
Retroviridae
Chemokines
Superoxides
Communicable Diseases
Up-Regulation
Inflammation
Therapeutics

ASJC Scopus subject areas

  • Immunology

Cite this

Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer. / Ahuja, Seema S; Brown, Margaret R.; Fleisher, Thomas A.; Ahuja, Sunil K; Malech, Harry L.

In: Journal of Immunology, Vol. 156, No. 11, 01.06.1996, p. 4345-4353.

Research output: Contribution to journalArticle

Ahuja, Seema S ; Brown, Margaret R. ; Fleisher, Thomas A. ; Ahuja, Sunil K ; Malech, Harry L. / Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer. In: Journal of Immunology. 1996 ; Vol. 156, No. 11. pp. 4345-4353.
@article{6f04df86a52d4f698215b2fefc89d4ac,
title = "Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer",
abstract = "Immunomodulatory cytokines have been used with success as adjunctive therapy in genetic disorders such as chronic granulomatous disease and infectious diseases such as leishmaniasis and leprosy. As the first step toward developing novel methods to deliver immunomodulatory cytokines, we used retrovirus-mediated somatic gene transfer techniques to produce IFN-γ from human peripheral blood CD34+ hemopoietic progenitor (PBHP) cells. After transduction, the PBHP cells were made to differentiate toward myelo- monocytic lineages. Only the PBHP-derived myelo-monocytic cells that were transduced with the IFN-γ cDNA produced IFN-γ (4 ± 1.3 ng of IFN-γ/106 PBHP cells). Despite a reduction in the proliferation of IFN-γ-transduced PBHP cells as well as a decrease in erythroid colony formation, there was an enhancement of monocyte differentiation and activation. Monocytes differentiated from the IFN-γ-transduced PBHP cells demonstrated 1) up- regulation of MHC class I and II Ag expression, 2) increased FcγRI expression, and 3) enhanced superoxide production in response to both opsonized zymosan (25-fold) and phorbol ester (3-fold). Furthermore, a functional response to a monocyte-specific chemokine, monocyte chemotactic protein-1 (mobilization of intracellular Ca2+) was seen only in the IFN- γ-transduced cells. Thus, PBHP cells transduced with IFN-γ cDNA produce not only biologically active IFN-γ, but also enhanced monocyte differentiation, resulting in an activated state that includes unique functions, such as responsiveness to monocyte chemotactic protein-1. These transduced activated monocytes may be specifically suited to cellular therapy requiring homing to sites of inflammation where their antimicrobicidal, cytotoxic, and APC functions plays an important role in host defense against foreign pathogens.",
author = "Ahuja, {Seema S} and Brown, {Margaret R.} and Fleisher, {Thomas A.} and Ahuja, {Sunil K} and Malech, {Harry L.}",
year = "1996",
month = "6",
day = "1",
language = "English (US)",
volume = "156",
pages = "4345--4353",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer

AU - Ahuja, Seema S

AU - Brown, Margaret R.

AU - Fleisher, Thomas A.

AU - Ahuja, Sunil K

AU - Malech, Harry L.

PY - 1996/6/1

Y1 - 1996/6/1

N2 - Immunomodulatory cytokines have been used with success as adjunctive therapy in genetic disorders such as chronic granulomatous disease and infectious diseases such as leishmaniasis and leprosy. As the first step toward developing novel methods to deliver immunomodulatory cytokines, we used retrovirus-mediated somatic gene transfer techniques to produce IFN-γ from human peripheral blood CD34+ hemopoietic progenitor (PBHP) cells. After transduction, the PBHP cells were made to differentiate toward myelo- monocytic lineages. Only the PBHP-derived myelo-monocytic cells that were transduced with the IFN-γ cDNA produced IFN-γ (4 ± 1.3 ng of IFN-γ/106 PBHP cells). Despite a reduction in the proliferation of IFN-γ-transduced PBHP cells as well as a decrease in erythroid colony formation, there was an enhancement of monocyte differentiation and activation. Monocytes differentiated from the IFN-γ-transduced PBHP cells demonstrated 1) up- regulation of MHC class I and II Ag expression, 2) increased FcγRI expression, and 3) enhanced superoxide production in response to both opsonized zymosan (25-fold) and phorbol ester (3-fold). Furthermore, a functional response to a monocyte-specific chemokine, monocyte chemotactic protein-1 (mobilization of intracellular Ca2+) was seen only in the IFN- γ-transduced cells. Thus, PBHP cells transduced with IFN-γ cDNA produce not only biologically active IFN-γ, but also enhanced monocyte differentiation, resulting in an activated state that includes unique functions, such as responsiveness to monocyte chemotactic protein-1. These transduced activated monocytes may be specifically suited to cellular therapy requiring homing to sites of inflammation where their antimicrobicidal, cytotoxic, and APC functions plays an important role in host defense against foreign pathogens.

AB - Immunomodulatory cytokines have been used with success as adjunctive therapy in genetic disorders such as chronic granulomatous disease and infectious diseases such as leishmaniasis and leprosy. As the first step toward developing novel methods to deliver immunomodulatory cytokines, we used retrovirus-mediated somatic gene transfer techniques to produce IFN-γ from human peripheral blood CD34+ hemopoietic progenitor (PBHP) cells. After transduction, the PBHP cells were made to differentiate toward myelo- monocytic lineages. Only the PBHP-derived myelo-monocytic cells that were transduced with the IFN-γ cDNA produced IFN-γ (4 ± 1.3 ng of IFN-γ/106 PBHP cells). Despite a reduction in the proliferation of IFN-γ-transduced PBHP cells as well as a decrease in erythroid colony formation, there was an enhancement of monocyte differentiation and activation. Monocytes differentiated from the IFN-γ-transduced PBHP cells demonstrated 1) up- regulation of MHC class I and II Ag expression, 2) increased FcγRI expression, and 3) enhanced superoxide production in response to both opsonized zymosan (25-fold) and phorbol ester (3-fold). Furthermore, a functional response to a monocyte-specific chemokine, monocyte chemotactic protein-1 (mobilization of intracellular Ca2+) was seen only in the IFN- γ-transduced cells. Thus, PBHP cells transduced with IFN-γ cDNA produce not only biologically active IFN-γ, but also enhanced monocyte differentiation, resulting in an activated state that includes unique functions, such as responsiveness to monocyte chemotactic protein-1. These transduced activated monocytes may be specifically suited to cellular therapy requiring homing to sites of inflammation where their antimicrobicidal, cytotoxic, and APC functions plays an important role in host defense against foreign pathogens.

UR - http://www.scopus.com/inward/record.url?scp=0029886978&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029886978&partnerID=8YFLogxK

M3 - Article

C2 - 8666806

AN - SCOPUS:0029886978

VL - 156

SP - 4345

EP - 4353

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -